Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations

被引:59
作者
Ersmark, K
Nervall, M
Hamelink, E
Janka, LK
Clemente, JC
Dunn, BM
Blackman, MJ
Samuelsson, B
Aqvist, J
Hallberg, A
机构
[1] Uppsala Univ, BMC, Dept Med Chem, S-75123 Uppsala, Sweden
[2] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden
[3] Natl Inst Med Res, Div Parasitol, London NWI 1AA, England
[4] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA
基金
英国医学研究理事会;
关键词
D O I
10.1021/jm050463l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of inhibitors of the malarial aspartic proteases Plm I and II have been synthesized with L-mannitol as precursor. These inhibitors are characterized by either a diacylhydrazine or a five-membered oxadiazole ring replacing backbone amide functionalities. Molecular dynamics simulations were applied in the design process. The computationally predicted Plm II K-i values were generally in excellent agreement with the biological results. The diacylhydrazine was found to be superior over the oxadiazole as an amide bond replacement in the Plm I and II inhibitors studied. An extensive flexibility of the S2 ' pocket was captured by the simulations predicting the binding mode of the unsymmetrical inhibitors. Plm I and II inhibitors with single digit nanomolar K-i values devoid of inhibitory activity toward human Cat D were identified. One compound, lacking amide bonds, was found to be Plm IV selective and very potent, with a K-i value of 35 nM.
引用
收藏
页码:6090 / 6106
页数:17
相关论文
共 69 条
[1]   NEW METHOD FOR PREDICTING BINDING-AFFINITY IN COMPUTER-AIDED DRUG DESIGN [J].
AQVIST, J ;
MEDINA, C ;
SAMUELSSON, JE .
PROTEIN ENGINEERING, 1994, 7 (03) :385-391
[2]   Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum [J].
Asojo, OA ;
Gulnik, SV ;
Afonina, E ;
Yu, B ;
Ellman, JA ;
Haque, TS ;
Silva, AM .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 327 (01) :173-181
[3]   Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 Å in complex with the inhibitors rs367 and rs370 [J].
Asojo, OA ;
Afonina, E ;
Gulnik, SV ;
Yu, B ;
Erickson, JW ;
Randad, R ;
Medjahed, D ;
Silva, AM .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :2001-2008
[4]   Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine [J].
Banerjee, R ;
Liu, J ;
Beatty, W ;
Pelosof, L ;
Klemba, M ;
Goldberg, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :990-995
[5]  
Berry C, 2000, Curr Opin Drug Discov Devel, V3, P624
[6]   Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active site [J].
Bjelic, S ;
Åqvist, J .
BIOCHEMISTRY, 2004, 43 (46) :14521-14528
[7]   Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents [J].
Boss, C ;
Richard-Bildstein, S ;
Weller, T ;
Fischli, W ;
Meyer, S ;
Binkert, C .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (11) :883-907
[8]   Novel procedure for the synthesis of 1,3,4-oxadiazoles from 1,2-diacylhydrazines using polymer-supported Burgess reagent under microwave conditions [J].
Brain, CT ;
Paul, JM ;
Loong, Y ;
Oakley, PJ .
TETRAHEDRON LETTERS, 1999, 40 (16) :3275-3278
[9]  
BREMAN J, 2001, AM J TROP MED HYG, V64
[10]   Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library [J].
Carroll, CD ;
Patel, H ;
Johnson, TO ;
Guo, T ;
Orlowski, M ;
He, ZM ;
Cavallaro, CL ;
Guo, J ;
Oksman, A ;
Gluzman, IY ;
Connelly, J ;
Chelsky, D ;
Goldberg, DE ;
Dolle, RE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (17) :2315-2320